- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00235326
Chronic Gastrointestinal Sequelae of an Acute Outbreak of Bacterial Gastroenteritis in Walkerton Ontario
March 16, 2009 updated by: McMaster University
Acute Bacterial dysentery leads to chronic symptoms of disturbed bowel habit in a minority of individuals.
This condition known as post infectious irritable bowel syndrome (PI-IBS) remains poorly understood.
This could allow material in the bowel to reach deeper tissues of the bowel wall leading to inflammation and changes in muscle and nerve function.
This is also early evidence that genetic programming of people with PI-IBS prevents them from turning off inflammation once it begins.
Literature suggests that IBS may develop at greater rates in individuals with pro-inflammatory genotype and that these individuals may be at increased risk of inflammatory bowel diseases (IBD).
Study Overview
Status
Completed
Conditions
Detailed Description
This research will study chronic gastrointestinal problems in the residents of Walkerton, Ontario region.
Determine whether acute bacterial infection is a risk factor for development of inflammatory bowel disease using the population of Walkerton as a cohort.
We hypothesize that exposure to bacterial infection leads to development of post infectious irritable bowel syndrome which is associated with an increase in intestinal permeability and immune activation with low grade intestinal inflammation and that this sequence of events will trigger inflammatory bowel disease in genetically susceptible individuals
Study Type
Observational
Enrollment (Actual)
4561
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Walkerton, Ontario, Canada, N0G 2V0
- Walkerton
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
residents of walkerton
Description
Inclusion Criteria:
- Participants must be residents of the Walkerton, Ontario region at the time of Outbreak who consented to the study
Exclusion Criteria:
- Non residents of Walkerton Ontario at the time of outbreak
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
2
Unexposed to gastroenteritis
|
|
1
Exposed to gastroenteritis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of Participants With Post Infectious Irritable Bowel Syndrome
Time Frame: 8 years
|
8 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: John k Marshall, MD, MSc, McMaster University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2002
Primary Completion (Actual)
August 1, 2008
Study Completion (Actual)
August 1, 2008
Study Registration Dates
First Submitted
October 6, 2005
First Submitted That Met QC Criteria
October 6, 2005
First Posted (Estimate)
October 10, 2005
Study Record Updates
Last Update Posted (Estimate)
April 22, 2009
Last Update Submitted That Met QC Criteria
March 16, 2009
Last Verified
March 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 02-026; 05-346
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.